Factors Predictive of Severe Multiple Sclerosis Disease Reactivation After Fingolimod Cessation

Conclusions: SDR may develop within the first 3 months after cessation of fingolimod. Patients with higher annualized relapse rates and lower Expanded Disability Status Scale scores before commencing fingolimod treatment were more likely to exhibit SDR.
Source: The Neurologist - Category: Neurology Tags: Original Articles Source Type: research